What is the recommended dose of artesunate (intravenous antimalarial medication) for the treatment of Plasmodium falciparum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intravenous Artesunate Dosing for Plasmodium falciparum Malaria

For treatment of complicated Plasmodium falciparum malaria, intravenous artesunate should be administered at 2.4 mg/kg body weight at 0,12, and 24 hours, then continued at 2.4 mg/kg daily until the patient can take oral medication. 1, 2, 3

Dosing Regimen Details

  • The first-line treatment for complicated P. falciparum malaria is intravenous artesunate, which should be administered immediately as a medical emergency 2, 3
  • The recommended dosing schedule is:
    • Initial dose: 2.4 mg/kg IV at 0 hours
    • Second dose: 2.4 mg/kg IV at 12 hours
    • Third dose: 2.4 mg/kg IV at 24 hours
    • Subsequent doses: 2.4 mg/kg IV daily 1
  • Continue IV artesunate until:
    • Patient can tolerate oral medication AND
    • Parasite density has decreased to <1% 1

Transition to Oral Therapy

  • Once the patient improves and can take oral medication, complete treatment with a full course of oral artemisinin-based combination therapy (ACT) 2, 3
  • The transition to oral therapy should occur after at least 24 hours of IV artesunate, but only when the patient is clinically improved 2
  • Preferred oral options include dihydroartemisinin-piperaquine or artemether-lumefantrine 1

Monitoring During Treatment

  • Monitor parasitemia every 12 hours until it declines to <1%, then every 24 hours until negative 2, 3
  • Monitor complete blood count, renal function, liver function, and metabolic parameters daily 3
  • Check for post-artesunate delayed hemolysis (PADH) by monitoring hemoglobin, haptoglobin, and lactate dehydrogenase at days 7,14,21, and 28 after treatment initiation 2

Alternative Treatment Options

  • If intravenous artesunate is unavailable, intravenous quinine dihydrochloride can be used as a second-line option 1
  • Quinine dosing: 20 mg salt/kg loading dose over 4 hours, followed by 10 mg/kg over 4 hours starting 8 hours after initiation, and then every 8 hours 1
  • Switch to oral therapy as soon as feasible, but not before completing 48 hours of IV treatment 1

Special Considerations

  • Artesunate provides faster parasite clearance and shorter ICU stays compared to quinine 2, 3
  • Use restrictive fluid management to avoid pulmonary or cerebral edema 2, 3
  • Consider acetaminophen (1g every 6 hours for 72 hours) for potential reno-protective effects in patients with acute kidney injury 2
  • Start antibiotics if bacterial co-infection is suspected, but continue only if blood cultures are positive 2

This dosing regimen is supported by multiple international guidelines and has been shown to be effective in reducing mortality from severe malaria compared to other treatments.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Complicated Malaria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Severe Malaria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.